Search for: "Abbott Laboratories (AP)" Results 1 - 20 of 22
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2023, 2:17 pm by Bill Marler
In April of this year I wrote the following post: The Abbott infant formula recall could have been prevented. [read post]
30 May 2023, 3:23 am by Seán Binder
Zenel Zhinipotoku and Llazar Semini report for AP News. [read post]
11 Feb 2014, 8:01 am by Howard Friedman
Abbott Laboratories, (9th Cir., Jan. 21, 2014) holding that heightened scrutiny must be applied to equal protection claims based on sexual orientation. [read post]
28 Oct 2011, 7:06 am by John Hopkins
Abbott LaboratoriesAbbott is into using lawsuits to further its own interests. [read post]
6 Sep 2011, 4:00 pm by FDABlog HPM
Karst –     A recent Citizen Petition submitted on behalf of Abbott Laboratories (“Abbott”) calls into question FDA’s authority for granting Therapeutic Equivalence (“TE”) ratings (i.e., “A” ratings) for drug products approved pursuant to FDC Act § 505(b)(2). [read post]
29 Jul 2011, 11:21 am by Steve Hall
The AP filing is, "Texas AG: Forensic panel can't consider older evidence in Willingham case," by Christopher Clausen. [read post]
18 Apr 2011, 8:12 am by Steve Hall
"Texas science panel adopts arson recommendations," is the AP report, via Google News. [read post]
8 Feb 2011, 1:42 pm by Steve Hall
And: The drug was developed by Abbott Laboratories in the 1930s and produced until about 2004, when Abbott spun off a new company called Hospira Inc. [read post]
18 Oct 2010, 9:15 pm by Christopher T. Hurley
Abbott Laboratories announced today its plan to pull its weight loss drug Meridia off the market in Canada. [read post]
12 Oct 2010, 3:15 am by Bob Kraft
" The AP reported, "Abbott Laboratories says it is withdrawing its diet pill Meridia in the US and Canada, almost a year after studies showed the drug increases the risk of heart attack and stroke in patients with a history of heart disease. [read post]
12 Oct 2010, 3:12 am by Bob Kraft
” The AP reported, “Abbott Laboratories says it is withdrawing its diet pill Meridia in the US and Canada, almost a year after studies showed the drug increases the risk of heart attack and stroke in patients with a history of heart disease. [read post]
31 Oct 2009, 4:06 pm by admin
October 31,  2009 – A summary review of environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]
30 Jun 2009, 8:39 am
Click here for the WSJ story; here for a report from the WSJ’s Health Blog; and here and here for reports from Bloomberg and the AP, respectively. [read post]
6 Feb 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
23 Oct 2008, 10:31 am
.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its application… [read post]
7 Jul 2008, 7:06 pm
" AP reporter, Lindsey Tanner--but not NYT reporter, Tara Parker Pope -- informed readers that he has worked as a consultant to Abbott Laboratories and Merck& Co.The 2008 AAP cholesterol recommendations are a crass example of how financial conflicts of interest can influence treatment recommendations by American professional medical associations. [read post]